VARILRIX CHICKENPOX VACCINE – 1

Varilrix is a vaccine used to prevent varicella, commonly known as chickenpox. It contains a live attenuated strain of the varicella-zoster virus, which stimulates the immune system to develop immunity against the disease. Varilrix is primarily administered to children, typically between 12 months and 12 years of age, but it can also be given to susceptible adolescents and adults.

The vaccine is effective in preventing chickenpox, which is characterized by an itchy rash, fever, and fatigue. In addition to preventing the primary infection, Varilrix also helps reduce the risk of severe complications associated with chickenpox, such as pneumonia, encephalitis, and secondary bacterial infections.

Varilrix is usually given as a single dose, but a second dose may be recommended for those at higher risk or for better immunity. Overall, Varilrix plays a crucial role in public health by reducing the incidence of chickenpox and its associated complications.